REFEX270.90

Refex Industries Ltd.

· Chemicals
₹ CrorePeersRCFRALLISRAINPRIVISCLSHARDACROPNFLSTYRENIXNEOGENMcap ₹3,717 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Revenue Growth+78.4-7.7
EBITDA Growth+43.6+70.2
EBIT Growth+33.7+90.2
Net Income Growth+70.3+28.6
EPS Growth+53.9+18.2
Total Assets Growth+125.5+58.0
Total Equity Growth+160.9+24.5
Cash from Operations Growth-9,389.2+140.5
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.